Brendan Foht is a writer and editor focused on bioethics, biotechnology, and science policy. He is associated with The New Atlantis, a journal of technology and society. His contributions to The Weekly Standard covered topics including gene editing, cloning, immunotherapy, and reproductive technology.
What should be done about human gene editing? Should it be used by scientists to help parents voluntarily choose to have the best possible children, leading to an all-around improvement in the gene pool? Or would such efforts render people with disabilities "unfit" for the human germline, further…
In a paper published online yesterday, scientists in China reported that they had successfully cloned macaques—a species of monkey commonly used in biomedical research. This announcement of the birth of the first cloned primates is another in a long line of “firsts” in the history of cloning,…
In a speech at JPMorgan’s 36th annual health care conference earlier this month, Bill Gates argued that investments in high-tech biomedical treatments for diseases like cancer could also help develop better ways to control the kinds of infectious diseases that afflict underdeveloped countries.
Pink Floyd, Jethro Tull, Yes, and the intellectual ambitions of prog rockers.
The decision by the British government earlier this summer to approve a suite of new technologies that would make possible the creation of human embryos with three genetic parents has brought a long-simmering and seemingly obscure bioethical debate into the public eye, raising questions not only…